期刊文献+

福辛普利联合左旋氨氯地平片治疗原发性高血压病疗效观察

下载PDF
导出
摘要 目的探讨福辛普利联合左旋氨氯地平片治疗原发性高血压病的临床疗效。方法回顾性分析笔者所在医院收治的90例原发性高血压患者的临床资料,所有90例患者,随机分为治疗组45例和对照组45例。治疗组采用福辛普利联合左旋氨氯地平片进行治疗;对照组采用福辛普利单独使用进行治疗,8周后对两组疗效进行比分析。结果治疗组血压明显下降,总有效率为97.8%,对照组总有效率为75.6%,两组疗效对比差异有统计学意义(P<0.05)。结论福辛普利联合左旋氨氯地平片治疗原发性高血压病疗效肯定,值得临床推广使用。
作者 邵金波
出处 《中国医学创新》 CAS 2010年第34期171-172,共2页 Medical Innovation of China
  • 相关文献

参考文献5

二级参考文献14

  • 1卫生部心血管病防治研究中心.中国心血管病报告2006.北京:中国大百科全书出版社,2007.
  • 2Liu L, Zhang Y, Liu G, et al. FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long- term placebo-controlled trial in Chinese hypertensive patients. J Hypertens, 2005,23 : 2157-2572.
  • 3Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004,363:2022-2031.
  • 4Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet ,2003,361 : 1149-1158.
  • 5Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press ,2007,16 : 13-19.
  • 6Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers : a quantitative overview. Hypertension, 2007,50 : 181 - 188.
  • 7Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin Ⅱ Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res,2008,31:657-664.
  • 8Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase Ⅲ, 12-week, muhicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed- dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage Ⅱ hypertension. Clin Ther, 2007,29 : 2667 -2676.
  • 9Chrysant SG. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension : focus on amlodipine/olmesartan combination. Drugs Today (Barc) ,2008,44:443-453.
  • 10Ichihara A, Kaneshiro Y, Sakoda M, et al. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker. J Cardiovasc Pharmacol,2007,49 : 161-166.

共引文献237

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部